Fast MDx was delighted to read an item in Genome Web covering our system obtaining the CE-IVDR mark for a fully automated, high-throughput open molecular diagnostic test system called NGX 124.

The system is slated for official launch later this year, the London-based firm said in a statement.

The NGX 124 was designed in collaboration with Festo, a Germany-based automation specialist, and uses Fast MDx’s four-channel qPCR thermal cycler and reverse transcription block technology. The system allows laboratories to automate lab-developed tests and research-use-only assays along with CE-IVDR-marked tests from independent manufacturers.